Building predictive ADMET models for early decisions in drug discovery.
Curr Opin Drug Discov Devel
; 7(1): 49-61, 2004 Jan.
Article
en En
| MEDLINE
| ID: mdl-14982148
This review discusses the current challenges facing researchers developing computational models to predict absorption, distribution, metabolism, excretion and toxicity (ADMET) for early drug discovery. The strengths and weaknesses of different modeling approaches are reviewed and a survey of recent strategies to model several key ADMET parameters, including intestinal permeability, blood-brain barrier penetration, metabolism, bioavailability and drug toxicities, is presented.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
Problema de salud:
1_medicamentos_vacinas_tecnologias
Asunto principal:
Farmacocinética
/
Preparaciones Farmacéuticas
/
Diseño de Fármacos
/
Modelos Moleculares
/
Canales de Potasio con Entrada de Voltaje
/
Modelos Biológicos
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Curr Opin Drug Discov Devel
Asunto de la revista:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Año:
2004
Tipo del documento:
Article
País de afiliación:
Estados Unidos